Increasing Consumer Demand for Genetic Screening Fuels the Growth of the Global Reproductive Genetics Market
Reproductive Genetics is the branch of science that deals with the
relationship between reproduction and genotype. It includes different
tests & procedures to offer needful information about the
probabilities of having a child in case of any specific genetic
disorder. It also helps predict & prevent genetic disorders during
reproductive procedures.
According to a new study by MarkNtel Advisors, the Global Reproductive Genetics Market
is likely to grow at a CAGR of 12% during the forecast period, i.e.,
2021-26. With the rising advanced stage pregnancies, there has been a
surging demand for Pre-Natal Genetic Screening & Testing as a part
of reproductive genetics to predict the risk of fetal chromosomal
abnormalities depending on age.
Further, Pre-Natal testing became
the need of the hour owing to the increasing number of cases of various
genetic disorders, such as Down syndrome, cleft palate, sickle cell
anemia, thalassemia, and fragile X syndrome. The leading industry
players in the Global Reproductive Genetics Market are ThermoFisher
Scientific, Eurofins Scientific SE, Natera Inc., BGI Genomics, Illumina,
Inc., Agilent Technologies, Inc., CENTOGENE AG, Fulgent Genetics, Inc.,
F. Hoffmann-La Roche Ltd, Invitae Corporation, Laboratory Corporation
of America Holdings, PerkinElmer, Inc., Myriad Genetics, Inc., OPKO
Health, Inc., Quest Diagnostics, and QIAGEN NV.
Based on the Application, the market divides into Aneuploidy, Structural Chromosomal Abnormality, and Single Gene Disorder. Of them all, Aneuploidy attained the largest share of the Global Reproductive Genetics Market. The surging number of Aneuploidy cases resulting in miscarriage is the most prominent aspect driving the need for reproductive genetic consultation and contributing to the overall market growth.
Comments
Post a Comment